Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers

Fabrizia Mariotti,1 Mirco Govoni,1 Germano Lucci,1 Debora Santoro,1 Marie Anna Nandeuil2 1Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy; 2Global Clinical Development, Chiesi S.A.S., Courbevoie, France Purpose: The purpose of this study was to evaluate safety, tolerability, and...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mariotti F, Govoni M, Lucci G, Santoro D, Nandeuil MA
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2018-10-01
Serie:	International Journal of COPD
Soggetti:	Healthy volunteers pulmonary disease chronic obstructive phosphodiesterase 4 inhibitors pharmacokinetics
Accesso online:	https://www.dovepress.com/safety-tolerability-and-pharmacokinetics-of-single-and-repeat-ascendin-peer-reviewed-article-COPD
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!